The cyclophilin inhibitor SCY-635 suppresses viral replication and induces endogenous interferons in patients with chronic HCV genotype 1 infection
Sam Hopkins(Scynexis (United States)), Philippe Gallay(Scripps Research Institute), Pamela Rusnak(Scynexis (United States)), Ann E. Sluder(Massachusetts General Hospital), James Baugh(Scripps Research Institute), Jacob Lalezari(Quest Clinical Research (United States)), Paul Kowalczyk(Scynexis (United States)), Yves Ribeill(Scynexis (United States)), Betty DiMassimo(Scynexis (United States)), Douglas M. Heuman, Bernard Scorneaux(Scynexis (United States)), Sarah Mosier(Scynexis (United States))
Cited by 92
Related Papers
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
|Science|1996|4.9k
All‐oral 12‐week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY‐3 phase III study
|Hepatology|2015|689
HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway
|Proceedings of the National Academy of Sciences|1997|483
HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase
|Cell|1995|355
Active Site Residues of Cyclophilin A Are Crucial for Its Signaling Activity via CD147
|Journal of Biological Chemistry|2002|338